SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615219-21-000090
Filing Date
2021-08-20
Accepted
2021-08-20 17:00:57
Documents
12
Period of Report
2021-08-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K flks-20210818.htm   iXBRL 8-K 36493
  Complete submission text file 0001615219-21-000090.txt   172310

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20210818.xsd EX-101.SCH 1924
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20210818_lab.xml EX-101.LAB 23892
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20210818_pre.xml EX-101.PRE 12541
5 EXTRACTED XBRL INSTANCE DOCUMENT flks-20210818_htm.xml XML 11255
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 211194470
SIC: 2834 Pharmaceutical Preparations